Researchers at the Dana-Farber Cancer Institute in Boston have developed a PET/CT database of clinical data that are not usually available through conventional PACS and HIS/RIS.
Researchers at the Dana-Farber Cancer Institute in Boston have developed a PET/CT database of clinical data that are not usually available through conventional PACS and HIS/RIS.
Jeffery Yap, Ph.D., and colleagues at the institute's nuclear medicine/PET department use the database to query previous patient studies. The database contains more than 100 parameters organized in a variety of tables to optimize data entry and retrieval. It provides PET acquisition time, FDG dose, uptake time, CT technique, and plasma glucose level, among other figures. The investigators presented their findings in a poster at the 2007 SNM meeting (J Nucl Med 2007;48[Suppl 2]:199P).
"We use this information to ensure each patient's scan is performed consistently for repeat visits," Yap said.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Intestinal Ultrasound Provide an Alternative for Evaluating Creeping Fat with Crohn’s Disease?
September 25th 2024Intestinal ultrasound demonstrated an 88.2 percent agreement with computed tomography enterography in characterizing creeping fat in patients with Crohn’s disease, according to new research.
FDA Clears Enhanced 3D Ultrasound Platform for Thyroid Imaging
September 23rd 2024The Piur tUS Infinity system reportedly reduces operator dependency with ultrasound through upgrading of two-dimensional ultrasound devices and access to 3D multiplanar image reconstructions of thyroid conditions.